1. Home
  2. BCRX vs WULF Comparison

BCRX vs WULF Comparison

Compare BCRX & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • WULF
  • Stock Information
  • Founded
  • BCRX 1986
  • WULF 1952
  • Country
  • BCRX United States
  • WULF United States
  • Employees
  • BCRX N/A
  • WULF N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • WULF EDP Services
  • Sector
  • BCRX Health Care
  • WULF Technology
  • Exchange
  • BCRX Nasdaq
  • WULF Nasdaq
  • Market Cap
  • BCRX 1.9B
  • WULF 1.9B
  • IPO Year
  • BCRX 1994
  • WULF 1995
  • Fundamental
  • Price
  • BCRX $9.21
  • WULF $4.08
  • Analyst Decision
  • BCRX Buy
  • WULF Strong Buy
  • Analyst Count
  • BCRX 6
  • WULF 9
  • Target Price
  • BCRX $15.50
  • WULF $7.97
  • AVG Volume (30 Days)
  • BCRX 3.0M
  • WULF 45.2M
  • Earning Date
  • BCRX 02-24-2025
  • WULF 02-28-2025
  • Dividend Yield
  • BCRX N/A
  • WULF N/A
  • EPS Growth
  • BCRX N/A
  • WULF N/A
  • EPS
  • BCRX N/A
  • WULF N/A
  • Revenue
  • BCRX $412,579,000.00
  • WULF $128,351,000.00
  • Revenue This Year
  • BCRX $38.44
  • WULF $110.61
  • Revenue Next Year
  • BCRX $21.23
  • WULF $107.50
  • P/E Ratio
  • BCRX N/A
  • WULF N/A
  • Revenue Growth
  • BCRX 29.92
  • WULF 131.22
  • 52 Week Low
  • BCRX $4.03
  • WULF $1.57
  • 52 Week High
  • BCRX $9.50
  • WULF $9.30
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 65.48
  • WULF 33.90
  • Support Level
  • BCRX $8.63
  • WULF $4.65
  • Resistance Level
  • BCRX $9.00
  • WULF $4.97
  • Average True Range (ATR)
  • BCRX 0.36
  • WULF 0.40
  • MACD
  • BCRX 0.07
  • WULF -0.03
  • Stochastic Oscillator
  • BCRX 85.20
  • WULF 0.00

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: